Evidence map›Paper›PMID 26528715›Full record

ArticlePloS one2015

MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism.

Dan Yu, George Makkar, Tuo Dong, Dudley K Strickland, Rajabrata Sarkar, Thomas Stacey Monahan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Role for the PIPJournal of cell communication and signaling · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Small GTPases and Their Role in Vascular Disease.International journal of molecular sciences · 2019
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dan YuDepartment of Surgery, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, United States of America; Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
George MakkarDepartment of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Tuo DongDepartment of Surgery, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, United States of America.
Dudley K StricklandDepartment of Surgery, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, United States of America; Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Rajabrata SarkarDepartment of Surgery, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, United States of America; Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Thomas Stacey MonahanDepartment of Surgery, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, United States of America; Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
University of Maryland, Baltimore · US

Funding

Mechanisms for cell specific modulation of proliferation and migrationIK2BX001553 · VA · BALTIMORE VA MEDICAL CENTER · PI MONAHAN, THOMAS S · 2012 to 2016
–
BLRD VA IK2 BX001553
6 · The paper itself

Abstract

backgroundOverexpression of the myristolated alanine-rich C kinase substrate (MARCKS) occurs in vascular proliferative diseases such as restenosis after bypass surgery. MARCKS knockdown results in arrest of vascular smooth muscle cell (VSMC) proliferation with little effect on endothelial cell (EC) proliferation. We sought to identify the mechanism of differential regulation by MARCKS of VSMC and EC proliferation in vitro and in vivo. METHODS AND

resultssiRNA-mediated MARCKS knockdown in VSMCs inhibited proliferation and prevented progression from phase G0/G1 to S. Protein expression of the cyclin-dependent kinase inhibitor p27kip1, but not p21cip1 was increased by MARCKS knockdown. MARCKS knockdown did not affect proliferation in VSMCs derived from p27kip1-/- mice indicating that the effect of MARCKS is p27kip1-dependent. MARCKS knockdown resulted in decreased phosphorylation of p27kip1 at threonine 187 and serine 10 as well as, kinase interacting with stathmin (KIS), cyclin D1, and Skp2 expression. Phosphorylation of p27kip1 at serine 10 by KIS is required for nuclear export and degradation of p27kip1. MARCKS knockdown caused nuclear trapping of p27kip1. Both p27kip1 nuclear trapping and cell cycle arrest were released by overexpression of KIS, but not catalytically inactive KIS. In ECs, MARCKS knockdown paradoxically increased KIS expression and cell proliferation. MARCKS knockdown in a murine aortic injury model resulted in decreased VSMC proliferation determined by bromodeoxyuridine (BrdU) integration assay, and inhibition of vascular wall thickening. MARCKS knockdown increased the rate of re-endothelialization.

conclusionsMARCKS knockdown arrested VSMC cell cycle by decreasing KIS expression. Decreased KIS expression resulted in nuclear trapping of p27kip1 in VSMCs. MARCKS knockdown paradoxically increased KIS expression in ECs resulting in increased EC proliferation. MARCKS knockdown significantly attenuated the VSMC proliferative response to vascular injury, but accelerated reestablishment of an intact endothelium. MARCKS is a novel translational target with beneficial cell type-specific effects on both ECs and VSMCs.

Indexed as

AnimalsCell ProliferationCyclin D1Cyclin-Dependent Kinase Inhibitor p27Endothelial CellsGene Expression Regulation, EnzymologicHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMiceMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MuscleMyristoylated Alanine-Rich C Kinase SubstrateSignal TransductionS-Phase Kinase-Associated ProteinsCCND1 protein, humanCcnd1 protein, mouseCDKN1B protein, humanCdkn1b protein, mouseCyclin D1Cyclin-Dependent Kinase Inhibitor p27Intracellular Signaling Peptides and ProteinsMARCKS protein, humanMarcks protein, mouseMembrane ProteinsMyristoylated Alanine-Rich C Kinase SubstrateS-Phase Kinase-Associated Proteins

Identifiers

PMID26528715
PMCPMC4631550
OpenAlexW2135741153

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.